Patent details

LUC00266 Product Name: drospirénone

Basic Information

Publication number:
LUC00266
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP192096725
Legal Status:
Pending & Published
Application number:
LUC00266
First applicant's nationality:
Procedural language:
French

Marketing Authorization

1

Marketing Authorization Number:
61678
Marketing Authorization Type:
Marketing Authorization Date:
22/10/2019
Marketing Authorization Status:
Claimed
Marketing Authorization Country:
Denmark (DK)

2

Marketing Authorization Number:
2021040055
Marketing Authorization Type:
Marketing Authorization Date:
01/04/2021
Marketing Authorization Status:
Claimed
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
08/06/2022
First Marketing Authorization date:
22/10/2019
Grant date:
Activation date:
Publication date:
08/06/2022
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
22/10/2034
SPC Extension Expiration:
22/10/2034
Rejection date:
Withdrawal date:

Owner

From:
08/06/2022
 
 

Name:
Laboratorios Leon Farma SA
Address:
c/ La Vallina s/n - Poligono Industrial Navatejera Villaquilambre, 24008 Leon, Spain (ES)

Agent

Name:
ARONOVA S.A.
From:
08/06/2022
Address:
PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Publication

Bulletin

Bulletin Heading:
SPC1
Bulletin edition number:
2022/08
Publication date:
01/07/2022
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

Other

Note:
(08/06/2022) Suspension de la procédure de délivrance sur requête du déposant / Suspension of the grant procedure at the request of the applicant
Filing date Document type Number of pages
08/06/2022 Marketing authorization 2
08/06/2022 Marketing authorization 1
08/06/2022 Application Form 4
08/06/2022 Marketing authorization 18
08/06/2022 General Document 2
08/06/2022 Marketing authorization 5
08/06/2022 Summary of the product caracteristics 14
08/06/2022 Outgoing Correspondence 1
08/06/2022 Publication 1
08/06/2022 Incoming Correspondence (Post) 1
08/06/2022 Outgoing Correspondence 1